Biology of Sport
eISSN: 2083-1862
ISSN: 0860-021X
Biology of Sport
Current Issue Manuscripts accepted About the journal Editorial board Abstracting and indexing Archive Ethical standards and procedures Contact Instructions for authors Journal's Reviewers Special Information
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2025
vol. 42
 
Share:
Share:
Original paper

Association of leisure-time aerobic physical activity time with apparent treatment-resistant hypertension: a study based on NHANES database

Wanling Huang
1
,
Dongqin Lai
1
,
Meie Zeng
1
,
Bin Chen
1
,
Shuifen Ye
1
,
Fenjing Li
1
,
Chunmei Huang
1

  1. General Practice Department, Longyan First Affiliated Hospital of Fujian Medical University, Longyan City, Fujian Province, 364000, China
Biol Sport. 2025;42(4):3–12
Online publish date: 2025/04/14
Article file
- 1_04218_Article.pdf  [0.83 MB]
Get citation
 
PlumX metrics:
 

INTRODUCTION

Hypertension is a common preventable risk factor that affects the incidence and mortality of cardiovascular disease (CVD) – related diseases and premature deaths globally and is a risk factor for many adverse cardiovascular outcomes, including peripheral or coronary artery disease, heart failure, myocardial infarction, and stroke [13]. One of the global objectives for non-communicable illnesses is to lower the prevalence of hypertension by 33% between 2010 and 2030, with an estimated 1.28 billion people globally suffering from hypertension [4]. Resistant hypertension (RH) is characterized by blood pressure that remains uncontrolled (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg) even after taking at least three antihypertensive drugs, or at least four antihypertensive drugs before blood pressure is brought under control [5]. Apparent treatment-resistant hypertension (aTRH) is the most common term in the clinic and in many studies, and the term is used because of the inability to rule out inaccurate blood pressure measurements, medication nonadherence leading to elevated blood pressure, or white coat effect (in-office blood pressure above target, but out-of-office blood pressure equal to or below the target value) and other pseudo-RH [68]. In 2018, American Heart Association’s scientific statement on aTRH stated that the prevalence of aTRH is 19.7%, or approximately 10.3 million U.S. adults with aTRH [9]. Regardless of blood pressure control, people with aTRH have an increased risk of coronary artery disease, heart failure, and other CVD, end-stage renal disease, and all-cause mortality [5, 10, 11]. aTRH is undoubtedly an important public health problem and therefore there is an urgent need to develop appropriate prevention strategies to avoid the development of lifethreatening diseases.

Clinical management of patients at any stage of hypertension cannot be separated from healthy lifestyle and pharmacologic interventions. The four major classes of drugs for hypertension include renin-angiotensin-aldosterone system (RAAS) blockers, beta blockers, calcium channel blockers, and thiazide or thiazide diuretics. Pharmacologic treatment significantly improves morbidity and mortality in hypertensive patients with CVD [12]. But in a combined analysis including 104 million individuals, it was found that less than half of people with hypertension received medication and only 23% of women and 18% of men ended up with controlled blood pressure [13]. Therefore, many clinical guidelines for hypertension worldwide suggest the use of non-pharmacological interventions throughout the entire course of hypertension treatment. A few examples of non-pharmacological therapies are cutting back on salt, eating more fruits and vegetables, exercising, giving up smoking, and switching to a low-fat dairy product [14, 15].

Exercise has been widely shown to have antihypertensive effects [1618]. Strong evidence suggests that engaging in moderate to high-intensity physical activities, especially aerobic exercise, can improve cardiorespiratory health and reduce incidence of hypertension [19]. Leisure-time aerobic physical activity (LTAPA) refers to aerobic behaviors that people engage in during their leisure time, including walking, running, biking, and soccer [20]. These exercises have been extensively studied and have been shown to have a positive effect on lowering blood pressure. Results from relevant randomized controlled trials suggest that leisure-time aerobic physical activities such as walking, soccer, and swimming can lower blood pressure levels in patients with hypertension [2123]. Additionally, a randomized controlled trial study on the cardiovascular effects of physical exercise on resistant hypertension revealed that physical exercise could lower blood pressure even in subjects with low response to drug therapy [24].

However, most of these studies were small sample trials and failed to adequately explore the association between LTAPA and aTRH. There is a lack of studies based on large sample data to assess the relationship between LTAPA and aTRH. Therefore, this study aimed to investigate the association between LTAPA and aTRH incidence and mortality through a large sample of clinical data from the National Health and Nutrition Survey (NHANES), so as to provide policymakers with a scientific basis for the prevention and treatment of aTRH.

MATERIALS AND METHODS

Data Source and Study Population

In order to evaluate the health and nutritional status of American adults and children, the National Center for Health Statistics (NCHS) of the United States conducted a study project called NHANES. The project used a sophisticated, multi-stage probabilistic sampling method to draw samples from the non-institutionalized civilian population of the United States. The NCHS Research Ethics Review Board approved the NHANES study protocol, and informed consent forms were signed by each participant. Relevant information can be accessed for free on the website (http://www.cdc.gov/nchs/nhanes.htm).

We utilized data from six cycles of NHANES spanning from 2007 to 2018 for this study. During this survey period, data were collected from 59,842 individuals. We excluded participants with missing data on hypertension diagnosis and non-hypertensive individuals (40,897), as well as participants with missing data on aTRH diagnosis and LTAPA (10,297). In addition, participants with missing data on multiple variables (age, gender, race, body mass index (BMI), aspartate aminotransferase (AST), smoking and alcohol drinking, estimated glomerular filtration rate (eGFR), poverty-to-income ratio (PIR), alanine aminotransferase (ALT), and diabetes) were also excluded (1,943). Finally, data from 6,705 participants were included, and the specific participant selection process is shown in Figure 1.

FIG. 1

NHANES 2007–2018 Sample Selection Flowchart.

/f/fulltexts/BS/55772/JBS-42-4-55772-g001_min.jpg

Leisure-Time Aerobic Physical Activity

The independent variable in this study was LTAPA, which was assessed in participants through the following two questions: (1) “Did you engage in at least 10 minutes of moderate-intensity activity in the last 30 days, such as brisk walking, cycling, golfing, or dancing, that only resulted in light perspiration or a small to moderate rise in respiration or heart rate?” (2) “During the past 30 days, did you perform at least 10 minutes of high-intensity exercise that caused substantial sweating or a large increase in breathing or heart rate, such as running, swimming, aerobics classes, or fast biking?” Participants who answered “yes” to the above questions were further asked about the specific type of exercise, the frequency of exercise per week, and the average duration of each exercise session [25]. Weekly LTAPA time was calculated using the following formula:

LTAPA Time Per Week = High Intensity LTAPA Per Day * High Intensity LTAPA Days Per Week * 2 + Moderate Intensity LTAPA Per Day * Moderate Intensity LTAPA Days Per Week [25].

According to the 2008 guidelines [26], the amount of LTAPA in this study was categorized into 3 classes: (1) exercise was sufficient if participants reported ≥ 150 minutes/week of moderate-intensity exercise, or ≥ 75 minutes/week of high-intensity exercise or an equivalent combination of ≥ 150 minutes/week; (2) if participants reported some exercise but not enough to meet the definition of adequate exercise (> 0 to < 150 minutes/week), then exercise was insufficient; and (3) if participants reported no moderate-intensity and highintensity exercise, then they were defined as inactive.

Definitions of Hypertension and aTRH

According to NHANES, patients with hypertension were defined as meeting one of the following criteria [27]: (a) had been told that they had hypertension or had taken and were taking antihypertensive medication; (b) had a mean systolic blood pressure on the NHANES test that was more than or equal to 130 mm Hg or a mean diastolic blood pressure that was greater than or equal to 80 mm Hg (Participants sat quietly for 5 minutes and then had their blood pressure measured 3 times, taking the average of the 2nd and 3rd measurements.).

aTRH is usually defined as uncontrolled blood pressure (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg) despite receiving ≥ 3 different antihypertensive medications or requiring ≥ 4 antihypertensive drugs to control blood pressure [5].

Covariates

The following categorical variables were included in the study as covariates: gender, age, race, BMI, PIR, smoking, alcohol drinking, eGFR, ALT, AST, and diabetes. Race was categorized as Mexican American, other Hispanic, non-Hispanic white, non-Hispanic black, and other race. PIR was calculated by dividing total household income by the annual poverty threshold determined by the U.S. Census Bureau based on household size; PIR was categorized into 3 categories: low (≤ 1.3), medium (1.3–3.5), and high (> 3.5), as recommended by the NHANES [28]. BMI (measured weight/height2) was categorized into 3 groups of < 25 kg/m2, 25–30 kg/m2 and ≥ 30 kg/m2 [29]. “Now smoking” is defined as having smoked more than 100 cigarettes in a lifetime and currently smoking every day or sometimes; “Former smoking” is defined as having smoked more than 100 cigarettes in a lifetime but not currently smoking; “Never smoking” is someone who has smoked less than 100 cigarettes in their lifetime [30]. According to the NHANES Alcohol Use Questionnaire, “In any one year, have you had at least a 12 oz. beer, a 5 oz. glass of wine, or one and half ounces of liquor” defines whether or not to drink alcohol [31]. Diabetes mellitus was defined in those who met one of the following criteria: a) physician notification of diabetes mellitus; b) taking hypoglycemic medication; c) glycosylated hemoglobin > 6.5 (%); and d) fasting blood glucose > 126 (mg/dL) [32]. The eGFR was calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, eGFR = 141 × min(Scr/κ, 1) α × max(Scr/κ, 1)-1.209 × 0.993Age × 1.018 [if female] × 1.159 [if black]; where Scr is the concentration of creatinine, and κ values was taken according to gender, 0.9 for males and 0.7 for females, and the α value was taken according to gender, -0.411 for males and -0.329 for females [33]. AST and ALT values were obtained from the NHANES laboratory data file and were measured using a RocheCobas 6000 (c501 module) Analyzer (Roche Diagnostics, Indianapolis, IN, USA) [34].

Survival Data

All-cause mortality refers to death from any cause. NHANES Public Link Mortality File was utilized to obtain the cause of death. This file contains mortality follow-up data for NHANES participants as of May 13, 2022, obtained through the National Death Index (NDI) linkage: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/datalinkage/linked_mortality/.

Statistical Analysis

Analysis was conducted using R software (version 4.2.1). The ‘tableone’ package [35] was used to draw a baseline table including participants with hypertension. Group participants based on whether they have aTRH, and report sample size and proportion for categorical variables, and the mean and standard deviation for continuous variables (n is unweighted, n(%), mean and Standard Deviation (SD) are weighted).

A weighted logistic regression model of association between recreational aerobic activity and aTRH was constructed using the “survey” package [36], with odds ratio (OR) and 95% confidence interval (95% CI) to quantify relationship. Regression model was tested by gradually adjusting for potential confounders. Model I, unadjusted, was designed to demonstrate the original association between LTAPA and aTRH, contributing to a preliminary understanding of the relationship between the variables. Model II, partially adjusted, adjusted for gender, age, race, PIR, alcohol drinking, smoking, and BMI. These variables are known risk factors for hypertension and cardiovascular disease and may be associated with participation in LTAPA. Model III, fully adjusted, further adjusted for diabetes mellitus, eGFR, AST, and ALT, which may influence blood pressure regulation through metabolic pathways or liver function, based on Model II to more fully assess the independent relationship between LTAPA and aTRH. In addition, subgroup analyses were conducted based on gender and alcohol drinking to explore the association between the two and whether there is interaction in different groups, and interaction term tests were performed. Weighted Cox regression models were utilized to analyze association between LTAPA and the all-cause mortality rate of aTRH patients. Weighted K-M curves were constructed using ‘jskm’ [37], and log-rank tests were utilized to test the differences in survival between groups. In this study, a two-sided p-value < 0.05 was considered statistically significant.

RESULTS

Baseline Characteristics of Participants

Baseline characteristics of overall study population and subgroups included in this study are shown in Table 1. 6,705 hypertensive patients were included, with 6,292 non-aTRH patients and 413 aTRH patients, with balanced gender ratios in each group. Baseline results showed significant differences in age, race, PIR, BMI, number of cases of diabetes, and eGFR values between aTRH patients and non-aTRH patients (p < 0.05). Among them, aTRH patients were older (68.15 vs. 61.75), and the number of obese (BMI > 30 kg/m2) and diabetes cases were higher; however, the eGFR values of aTRH patients were significantly lower than those of non-aTRH patients (68.26 mL/min/1.73 m2 vs 79.47 mL/min/1.73 m2, p < 0.001). It is worth noting that the weekly LTAPA time of aTRH patients was significantly lower than that of non-aTRH patients (76.15 vs. 103.16, p = 0.016).

TABLE 1

Characteristics of NHANES participants with hypertension between 2007–2018

CharactersTotalNon-Resistant hypertensionResistant hypertensionP Value
Overall67056292 (95.1)413 (4.9)

Gender, N (%)0.992
Female3452 (52.8)3245 (52.8)207 (52.8)
Male3253 (47.2)3047 (47.2)206 (47.2)

Age, (years), mean (SD)62.06 (12.63)61.75 (12.62)68.15 (11.19)< 0.001

Race, N (%)< 0.001
Mexican American713 (4.6)676 (4.6)37 (4.5)
Other Hispanic592 (3.9)564 (3.9)28 (3.6)
Non-Hispanic White3108 (73.0)2937 (73.4)171 (65.4)
Non-Hispanic Black1743 (12.8)1590 (12.3)153 (22.2)
Other race549 (5.8)525 (5.8)24 (4.4)

PIR, N (%)0.003
 ≤ 1.32058 (19.5)1913 (19.3)145 (24.1)
1.3–3.52716 (38.7)2551 (38.5)165 (44.1)
> 3.51931 (41.8)1828 (42.3)103 (31.8)

BMI (kg/m2), N (%)0.032
< 251090 (14.8)1044 (14.9)46 (11.3)
25–302155 (31.5)2041 (31.8)114 (26.3)
 ≥ 303460 (53.7)3207 (53.2)253 (62.4)

Smoking, N (%)0.232
Never smoking3347 (49.8)3145 (49.8)202 (50.0)
Former smoking2347 (36.1)2190 (35.9)157 (39.2)
Now Smoking1011 (14.1)957 (14.3)54 (10.8)

Alcohol drinking, N (%)0.123
No1989 (24.3)1857 (24.1)132 (28.3)
Yes4716 (75.7)4435 (75.9)281 (71.7)

Diabetes, N (%)< 0.001
No4123 (66.8)3927 (67.6)196 (49.9)
Yes2582 (33.2)2365 (32.4)217 (50.1)

eGFR (mL/min/1.73 m2), mean (SD)78.93 (21.95)79.47 (21.69)68.26 (24.12)< 0.001

AST (U/L), mean (SD)26.04 (16.44)26.06 (16.69)25.67 (10.42)0.663

ALT (U/L), mean (SD)25.18 (22.82)25.26 (23.23)23.6 (12.51)0.128

Leisure-time aerobic physical activity time (min/week), mean (SD)101.85 (175.81)103.16 (176.47)76.15 (160.59)0.016

[i] Note: n is not weighted and n(%), Mean and SD are weight-adjusted. PIR, Poverty-to-income ratio; BMI = body mass index; eGFR = estimated glomerular filtration rate; AST = aspartate aminotransferase; ALT = alanine aminotransferase

Association of LTAPA Time with aTRH

To analyze the possible association of LTAPA time with aTRH, we constructed three models using weighted Logistics model to analyze the association between weekly LTAPA time and aTRH (Table.2). In the continuous Model I without adjusting confounding variables, increased LTAPA time was associated with a reduced risk of developing aTRH (OR = 0.939, 95%CI [0.884,0.999], p = 0.045). In the adjusted Model II and III, the corresponding risks decreased. However, this association was not significant in models after adjusting for confounding variables, reflecting the confounding effects of these variables.

TABLE 2

Associations between leisure-time aerobic physical activity time and OR (95% confidence intervals) for resistant hypertension

Leisure-time physical activity time (min/week)Model IModel IIModel III
Continuous0.939 (0.884, 0.999), 0.0450.973 (0.916, 1.033), 0.3650.996 (0.981, 1.011), 0.578

Categorical
0Ref.Ref.Ref.
0–900.892 (0.555, 1.432), 0.6321.010 (0.628, 1.624), 0.9661.066 (0.669, 1.700), 0.784
 ≥ 900.676 (0.496, 0.923), 0.0140.844 (0.622, 1.146), 0.2740.896 (0.660, 1.216), 0.475
Ptrend0.0150.2900.508

[i] Model I was unadjusted. Model II: adjust for gender, age, race, PIR, alcohol, smoke and BMI. Model III: model II plus adjustment for diabetes, eGFR, AST and ALT.

Weighted tertile groups were created based on LTAPA time, with the group of 0 minutes of aerobic exercise per week as the reference. The association between weekly aerobic exercise time and aTRH was further analyzed. The results showed that in Model I without adjusting for covariates, compared to the group with 0 minutes of aerobic exercise per week, participants with ≥ 90 minutes of aerobic exercise per week were associated with the decreased risk of aTRH significantly (OR = 0.676, 95% CI [0.496, 0.923], p = 0.014). In Model II adjusting for some covariates (OR = 0.844, 95% CI [0.622, 1.146]) and Model III adjusting for all covariates (OR = 0.896, 95% CI [0.660, 1.216]), the risk of aTRH in the group with ≥ 90 minutes of aerobic exercise per week decreased but not significantly (p > 0.05). Ptrend represents the trend change of LTAPA time across weighted tertile groups. A significant trend change was only observed in Model I (p = 0.015), indicating that in the model without adjusting for confounding variables, increasing LTAPA time was associated with the decreased risk of aTRH.

Stratified Analysis

The results of the interaction term test for subgroup analysis showed a significant interaction by gender (p for interaction = 0.045 < 0.05), therefore, we further explored association of LTAPA time with aTRH when stratified by gender. The results are shown in Table.3, Model III showed that association of LTAPA time with aTRH prevalence was more significant in females (Female. OR = 0.896, 95%CI [0.811, 0.989], p = 0.029), and this association was not significant in males (Male: OR = 1.027, 95% CI [0.961, 1.099], p = 0.422).

TABLE 3

Associations between leisure-time aerobic physical activity time and OR (95% confidence intervals) for resistant hypertension group by gender

Leisure-time aerobic physical activity timeModel IModel IIModel IIIP for interaction
Gender0.045

Female0.836 (0.747, 0.936), 0.0020.882 (0.799, 0.973), 0.0130.896 (0.811, 0.989), 0.029

Male0.990 (0.922, 1.062), 0.7751.017 (0.949, 1.089), 0.6311.027 (0.961, 1.099), 0.422

[i] Model I was unadjusted. Model II: adjust for age, race, PIR, alcohol, smoke and BMI. Model III: model II plus adjustment for diabetes, eGFR, aspartate aminotransferase and alanine aminotransferase.

Given that the relationship between alcohol drinking and blood pressure has been a widely studied topic [38], we further conducted a stratified analysis based on whether female patients drink alcohol. As shown in Table 4, we found that in female patients who did not drink alcohol, the fully adjusted Model III indicated a significant relationship between LTAPA time and aTRH (OR = 0.843, 95%CI [0.714, 0.994], p = 0.043). In female patients who drink alcohol, this association was not significant (OR = 0.911, 95% CI [0.809, 1.027], p = 0.126).

TABLE 4

Associations between leisure-time aerobic physical activity time and OR (95% confidence intervals) for female participants with resistant hypertension group by alcohol drinking

Leisure-time aerobic physical activity timeModel IModel IIModel III
Alcohol drinking

No0.789 (0.661, 0.942), 0.0090.832 (0.704, 0.983), 0.0310.843 (0.714, 0.994), 0.043
Yes0.859 (0.752, 0.981), 0.0250.897 (0.798, 1.008), 0.0680.911 (0.809, 1.027), 0.126

[i] Model I was unadjusted. Model II: adjust for age, race, PIR, smoke and BMI. Model III: model II plus adjustment for diabetes, eGFR, aspartate aminotransferase and alanine aminotransferase.

Survival Analysis

Relationship between LTAPA time and all-cause mortality rate of aTRH patients was analyzed through weighted Cox regression analysis. As listed in Table 5, in the continuous models Model I, II, and III, an increase in LTAPA time was associated with significant reduction of all-cause mortality risk of aTRH patients (HR < 1, p < 0.05). Furthermore, aTRH patients were divided into inactive group (0 min/week), insufficient group (0–150 min/week), and sufficient exercise group (≥ 150 min/week) based on LTAPA time, and the all-cause mortality risk of each group was compared. Compared to inactive group, Model I, II, and III all showed a significant decrease in risk of all-cause mortality in group with insufficient exercise (HR < 1, p < 0.05). The group with sufficient exercise only showed a significant reduction in risk of all-cause mortality in Model I (HR < 1, p < 0.05). In addition, we also conducted a trend test, and the results showed that all Cox regression models exhibited a trend, indicating that overall, as the LTAPA time increased, risk of all-cause mortality in aTRH patients decreased (Ptrend < 0.05).

TABLE 5

Cox regression analysis of leisure-time aerobic physical activity time with all-cause mortality in participants with resistant hypertension

Leisure-time aerobic physical activity time (min/week)Model IModel IIModel III
Continuous0.827 (0.733, 0.932), 0.0020.877 (0.797, 0.966), 0.0080.900 (0.831, 0.976), 0.010

Categorical
Inactive (0)Ref.Ref.Ref.
Insufficient (0–150)0.262 (0.145, 0.472) < 0.0010.362 (0.189, 0.695), 0.0020.444 (0.230, 0.854), 0.015
Sufficient (≥ 150)0.447 (0.263, 0.762), 0.0030.555 (0.296, 1.040), 0.0660.635 (0.362, 1.116), 0.114

Ptrend0.0010.0180.046

[i] Model I was unadjusted. Model II: adjust for gender, age, race, PIR, alcohol, smoke and BMI. Model III: model II plus adjustment for diabetes, eGFR, aspartate aminotransferase and alanine aminotransferase.

After adjusting for all confounding factors, we plotted Kaplan-Meier survival curve for all-cause mortality (Figure 2). Compared to aTRH patients in inactive group, survival time of aTRH patients in the group with insufficient exercise and group with sufficient exercise was significantly prolonged (Log-rank p < 0.001), while no significant difference was seen between the group with insufficient exercise and the group with sufficient exercise (Log-rank p = 0.190).

DISCUSSION

This study aimed to delineate relationship between LTAPA and aTRH. The results indicated that increasing LTAPA time was associated with significant reduction of the risk of aTRH incidence (p < 0.05). This association was more significant in non-drinking women. According to a weighted Cox regression analysis, significant negative association between LTAPA time and risk of all-cause mortality was observed and the risk tended to decline as LTAPA length increased. Kaplan-Meier survival curves also demonstrated that compared to the inactive group, patients in the insufficient exercise and sufficient exercise groups had significantly prolonged survival time (Log-rank p < 0.001).

In this study, the proportion of obese individuals among aTRH patients was 62.4% vs. 53.2%) and the proportion of diabetes patients (50.1% vs. 32.4%) were significantly higher in aTRH patients than in non-aTRH patients. The eGFR of aTRH patients was significantly lower than that of non-aTRH patients (68.26 mL/min/1.73 m2 vs. 79.47 mL/min/1.73 m2). This is consistent with previous studies, as Kaczmarski et al. revealed that aTRH patients had a higher prevalence of diabetes compared to non-aTRH patients (39.5% vs. 24.5%), and the eGFR of aTRH patients was lower than non-aTRH patients (68 mL/min/1.73 m2 vs. 82 mL/min/1.73 m2) [39].

The reason for the higher proportion of diabetes patients in aTRH may be closely related to the reduced insulin secretion and insulin resistance in diabetes patients. Blood vessels are an important target organ of insulin, and insulin can stimulate endothelial cells to produce NO (Nitric Oxide) (NO is one of the important endogenous blood pressure regulators) [40, 41]. Insulin resistance can cause endothelial dysfunction [40, 42]. Therefore, diabetes patients may be more prone to developing hypertension. eGFR is an important indicator of renal function, and a decrease in eGFR indicates impaired kidney function. Muntner et al. reported that aTRH patients have a higher risk of end-stage renal disease [5].

FIG. 2

Kaplan-Meier Survival Curves for All-Cause Mortality by Leisure-Time Aerobic Physical Activity Time

/f/fulltexts/BS/55772/JBS-42-4-55772-g002_min.jpg

Exercise that the body does when there is a sufficient supply of oxygen is referred to as aerobic exercise. Long length, rhythmic, and moderate intensity are the hallmarks of aerobic exercise. Walking quickly, running, swimming, cycling, calisthenics, and jumping rope are examples of common aerobic workouts. After assessing the findings of 34 meta-analyses, the EAPC and ESC Council on Hypertension produced a consensus paper in March 2021 on customized exercise prescription for the prevention and treatment of hypertension. This document advocated aerobic exercise as the primary option of physical activity for patients with hypertension and can help lower patients’ mean systolic and diastolic blood pressure by 4.9 to 12.0 mmHg and 3.4 to 5.8 mmHg, respectively [43]. Endothelial dysfunction is one of the characteristic abnormal changes in hypertension, and the NO-mediated diastolic vascular pathway is thought to be important for blood pressure regulation [44]. Exercise can improve endothelium-dependent vasodilation and increase vascular NO generation [45, 46]. Aerobic exercise can effectively reduce ROS in oxidative stress-associated diseases like hypertension, and reduction of ROS is crucial for protecting endothelial cell structure and NO activity [47]. Li et al.’s study also suggests that long-term aerobic exercise can improve insulin signaling, thereby restoring vascular dilation and lowering blood pressure [48]. Zhang et al.’s study also shows that engaging in moderate-intensity physical activity for more than 300 minutes per week can reduce the incidence of RH by 17% [15]. Physical activity in this study refers to activities related to work, transportation, and leisure, and it did not specify whether aerobic exercise alone can reduce the incidence of RH. Therefore, this study further explored association of LTAPA with RH and obtained positive results. In addition, our study also indicated that an increase in LTAPA time was beneficial in reducing the risk of all-cause mortality and prolonging survival time in patients with aTRH. Therefore, for patients with hypertension, the importance of LTAPA in disease control should be emphasized, and it is actively advocated to strengthen blood pressure management by changing lifestyle to reduce risk of aTRH and mortality.

There are gender differences in RH in terms of demographics, lifestyle, and clinical aspects. For example, women account for a higher proportion of patients with RH [49, 50] and the control rate of blood pressure in women is lower than that in men [49]; while male patients are often younger than female patients, visceral organ damage is more common, and risk of cardiovascular events is higher [51]. Therefore, it is necessary to explore association of LTAPA time with aTRH at the gender level. It is worth noting that our study suggested that association of LTAPA time with aTRH was more significant in women, especially in non-drinking female patients. This research result may be related to the different regulatory mechanisms of vascular function and blood pressure in women and men. For example, with aging and obesity, women have a greater increase in sympathetic nerve activity than men, and this increase in sympathetic nerve activity is mainly reflected in higher blood pressure; women have lower reflex sensitivity of pressure receptors than men, resulting in a lower rate of blood pressure control in women than in men; and lower estrogen levels in postmenopausal women have been linked to activation of renin-angiotensin-aldosterone system, which elevates blood pressure by releasing angiotensin II and angiotensin III to constrict systemic vasculature, and with activation of sympathetic nervous system and reduced vascular NO bioavailability [52]. The mechanisms by which aerobic exercise reduces blood pressure include enhancing sensitization of pressure receptors [53, 54], reducing sympathetic nerve activity to lower blood pressure and thus reducing vasoconstrictor release [19, 53]. Similarly, alcohol drinking causes an increase in blood pressure, with studies reporting a 1 mmHg increase in blood pressure for every 1 g of alcohol ingested [55]. Vacca et al. stated that the adverse effects of alcohol on blood pressure can be mediated through neurohormonal mechanisms, such as by activating sympathetic nervous system causing an elevated risk of hypertension, which in turn alters sensitivity of vascular pressure receptors [38]. This suggests that alcohol drinking may reduce the effect of LTAPA on blood pressure in female patients. In conclusion, gender-specific exercise strategies should be considered, and tailored treatment strategies for hypertension patients should be developed by combining a healthy lifestyle to lower risk of mortality.

This study investigated the link between LTAPA time and aTRH by doing a cross-sectional analysis of the NHANES data from 2007 to 2018. This is a cross-sectional study with a large sample size, and our results offer evidence in favor of using non-pharmacological treatments like LTAPA to avoid aTRH. This study is constrained, though. Firstly, because of the cross-sectional design of this study, although an association between LTAPA time and the risk of aTRH prevalence was observed, it was not possible to determine whether this association was causal. We will further conduct high-quality prospective cohort studies to validate the results of this study. Furthermore, the blood pressure measurements in this study only included clinic blood pressure and did not include dynamic blood pressure monitoring, which may lead to data bias. In addition, LTAPA data in this study was self-reported by patients, and participants may not have been able to accurately recall their frequency and duration of exercise over time, which could affect the accuracy of the data. Also, the lack of objective means of validation for self-reported data may lead to bias. Finally, although this study had a large sample size, the NHANES participants were primarily U.S. adults and may not be fully representative of populations in other countries or regions.

CONCLUSIONS

This study suggested that increased LTAPA time was significantly associated with a reduced risk of aTRH prevalence, especially in female patients who do not consume alcohol. It is recommended that future research should focus on gender differences, with an emphasis on female-specific intervention trials, to explore the effects of specifically designed exercise programs (e.g., combining aerobic exercise and strength training) on blood pressure control and cardiovascular health in female hypertensive patients. In addition, LTAPA was significantly beneficial in reducing the risk of all-cause mortality and prolonging survival time in patients with aTRH. Future studies should utilize a high-quality prospective cohort design incorporating ambulatory blood pressure monitoring and objective exercise tracking tools to validate our results and explore potential causal mechanisms. In summary, this study provides data support for LTAPA as a nonpharmacological intervention for the prevention and treatment of aTRH and emphasizes its importance in the management of hypertension.

Ethics approval and consent to participate

Before data from this study were included in the NHANES public database, all participants signed informed consent forms, adhered to the principles outlined in the Declaration of Helsinki, and were reviewed and approved by the NCHS Ethical Review Board.

Availability of data and materials

All the data within this manuscript could be gotten from corresponding author at reasonable request.

Conflict of interest

The authors declare that they have no known conflict of interest.

Funding

No Funding

Authors’ contributions

Wanling Huang: Conceptualization, Draft

Dongqin Lai: Data collection, Draft

Meie Zeng: Writing – review & editing, Investigation

Bin Chen: Data analysis, Data collection, Writing – review & editing

Shuifen Ye: Methodology, Project administration

Fenjing Li: Visualization, Investigation

Chunmei Huang: Resources, Software

REFERENCES

1 

Rapsomaniki E, Timmis A, George J, Pujade odriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014; 383(9932):1899–911.

2 

Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, et al. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects. Front Endocrinol (Lausanne). 2021; 12:721135.

3 

Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study. Sci Rep. 2018; 8(1):9418.

4 

Organization WH. Hypertension 2023 [Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension.

5 

Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, et al. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipi owering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2014; 64(5):1012–21.

6 

Berra E, Azizi M, Capron A, Hoieggen A, Rabbia F, Kjeldsen SE, et al. Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatmen esistant Hypertension. Hypertension. 2016; 68(2):297–306.

7 

Calhoun DA. Apparent and true resistant hypertension: why not the same? J Am Soc Hypertens. 2013; 7(6):509–11.

8 

Judd E, Calhoun DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014; 28(8):463–8.

9 

Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P. Prevalence of Apparent Treatmen esistant Hypertension in the United States. Hypertension. 2019; 73(2):424–31.

10 

Smith SM, Huo T, Gong Y, Handberg E, Gulati M, Merz CN, et al. Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women’s Heart Disease. J Womens Health (Larchmt). 2016; 25(10):996–1003.

11 

Smith SM, Huo T, Delia Johnson B, Bittner V, Kelsey SF, Vido Thompson D, et al. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBIsponsored WISE Study. J Am Heart Assoc. 2014; 3(1):e000660.

12 

Musini VM, Tejani AM, Bassett K, Puil L, Wright JM. Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database Syst Rev. 2019; 6(6):CD000028.

13 

Collaboration NCDRF. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304):957–80.

14 

Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021; 18(11):785–802.

15 

Zhang W, Xu R, Cai Z, Zheng X, Zheng M, Ni C. Association between physical activity and resistant hypertension in treated hypertension patients: analysis of the national health and nutrition examination survey. BMC Cardiovasc Disord. 2023; 23(1):289.

16 

Kumagai H, Miyamot ikami E, Someya Y, Kidokoro T, Miller B, Kumagai ME, et al. Sports activities at a young age decrease hypertension ris he J-Fit(+) study. Physiol Rep. 2022; 10(12):e15364.

17 

Rego ML, Cabral DA, Costa EC, Fontes EB. Physical Exercise for Individuals with Hypertension: It Is Time to Emphasize its Benefits on the Brain and Cognition. Clin Med Insights Cardiol. 2019; 13:1179546819839411.

18 

Lin M, Lin Y, Li Y, Lin X. Effect of exercise training on blood pressure variability in adults: A systematic review and meta-analysis. PLoS One. 2023; 18(10):e0292020.

19 

Bakker EA, Sui X, Brellenthin AG, Lee DC. Physical activity and fitness for the prevention of hypertension. Curr Opin Cardiol. 2018; 33(4):394–401.

20 

Hulteen RM, Smith JJ, Morgan PJ, Barnett LM, Hallal PC, Colyvas K, et al. Global participation in sport and leisure-time physical activities: A systematic review and meta-analysis. Prev Med. 2017; 95:14–25.

21 

Cooper AR, Moore LA, McKenna J, Riddoch CJ. What is the magnitude of blood pressure response to a programme of moderate intensity exercise? Randomised controlled trial among sedentary adults with unmedicated hypertension. Br J Gen Pract. 2000; 50(461):958–62.

22 

Mohr M, Nordsborg NB, Lindenskov A, Steinholm H, Nielsen HP, Mortensen J, et al. High-intensity intermittent swimming improves cardiovascular health status for women with mild hypertension. Biomed Res Int. 2014; 2014:728289.

23 

Nóbrega TKSd, Moura Junior JS, Brito AdF, Gonçalves MCR, Martins CdO, Silva AS. Caminhada/corrida ou uma partida de futebol recreacional apresentam efetividade semelhante na indução de hipotensão pós-exercício. Revista Brasileira de Medicina do Esporte. 2013; 19.

24 

Dimeo F, Pagonas N, Seibert F, Arndt R, Zidek W, Westhoff TH. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension. 2012; 60(3):653–8.

25 

Zhao G, Li C, Ford ES, Fulton JE, Carlson SA, Okoro CA, et al. Leisure-time aerobic physical activity, musclestrengthening activity and mortality risks among US adults: the NHANES linked mortality study. Br J Sports Med. 2014; 48(3):244–9.

26 

Services USDoHaH. 2008 Physical Activity Guidelines for Americans 2008 [Available from: http://www.health.gov/paguidelines/guidelines/default.aspx.

27 

Ciardullo S, Grassi G, Mancia G, Perseghin G. Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022; 34(4):365–71.

28 

Stebbins RC, Noppert GA, Aiello AE, Cordoba E, Ward JB, Feinstein L. Persistent socioeconomic and racial and ethnic disparities in pathogen burden in the United States, 1999–2014. Epidemiol Infect. 2019; 147:e301.

29 

Tian X, Xue B, Wang B, Lei R, Shan X, Niu J, et al. Physical activity reduces the role of blood cadmium on depression: A cross-sectional analysis with NHANES data. Environ Pollut. 2022; 304:119211.

30 

Zhang Y, Liu W, Zhang W, Cheng R, Tan A, Shen S, et al. Association between blood lead levels and hyperlipidemiais: Results from the NHANES (1999–2018). Front Public Health. 2022; 10:981749.

31 

Dong X, Li S, Sun J, Li Y, Zhang D. Association of Coffee, Decaffeinated Coffee and Caffeine Intake from Coffee with Cognitive Performance in Older Adults: National Health and Nutrition Examination Survey (NHANES) 2011–2014. Nutrients. 2020; 12(3).

32 

Zhao Y, Li H. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease. Scand J Gastroenterol. 2022; 57(7):872–7.

33 

Ma Y, Hu Q, Yang D, Zhao Y, Bai J, Mubarik S, et al. Combined exposure to multiple metals on serum uric acid in NHANES under three statistical models. Chemosphere. 2022; 301:134416.

34 

Chen G, Fan L, Yang T, Xu T, Wang Z, Wang Y, et al. Prognostic nutritional index (PNI) and risk of non-alcoholic fatty liver disease and advanced liver fibrosis in US adults: Evidence from NHANES 2017–2020. Heliyon. 2024; 10(4):e25660.

35 

Panos A, Mavridis D. TableOne: an online web application and R package for summarising and visualising data. Evid Based Ment Health. 2020; 23(3):127–30.

36 

RDocumentation. survey (version 4.2-1) [Available from: https://rdocumentation.org/packages/survey/versions/4.2-1.

37 

38 

Vacca A, Bulfone L, Cicco S, Brosolo G, Da Porto A, Soardo G, et al. Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story. Nutrients. 2023; 15(4).

39 

Kaczmarski KR, Sozio SM, Chen J, Sang Y, Shafi T. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES). BMC Nephrol. 2019; 20(1):138.

40 

Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007; 28(5):463–91.

41 

Puzserova A, Kopincova J, Bernatova I. [The role of endothelium and nitric oxide in the regulation of vascular tone]. Cesk Fysiol. 2008; 57(2–3):53–60.

42 

Jiang H, Liu Y, Guo H, Liu Z, Li Z. The association between the triglycerideglucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024; 24(1):234.

43 

Hanssen H, Boardman H, Deiseroth A, Moholdt T, Simonenko M, Krankel N, et al. Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on Hypertension. Eur J Prev Cardiol. 2022; 29(1):205–15.

44 

Bernatova I. Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence? Biomed Res Int. 2014; 2014:598271.

45 

Peters PG, Alessio HM, Hagerman AE, Ashton T, Nagy S, Wiley RL. Short-term isometric exercise reduces systolic blood pressure in hypertensive adults: possible role of reactive oxygen species. Int J Cardiol. 2006; 110(2):199–205.

46 

McGowan CL, Visocchi A, Faulkner M, Verduyn R, Rakobowchuk M, Levy AS, et al. Isometric handgrip training improves local flow-mediated dilation in medicated hypertensives. Eur J Appl Physiol. 2007; 99(3):227–34.

47 

Roque FR, Briones AM, Garci edondo AB, Galan M, Martine evelles S, Avendano MS, et al. Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension. Br J Pharmacol. 2013; 168(3):686–703.

48 

Li QX, Xiong ZY, Hu BP, Tian ZJ, Zhang HF, Gou WY, et al. Agingassociated insulin resistance predisposes to hypertension and its reversal by exercise: the role of vascular vasorelaxation to insulin. Basic Res Cardiol. 2009; 104(3):269–84.

49 

Brambilla G, Bombelli M, Seravalle G, Cifkova R, Laurent S, Narkiewicz K, et al. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens. 2013; 31(10):2018–24.

50 

Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Jr., Crowley K, et al. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J. 2013; 34(16):1204–14.

51 

Joo HJ, Yum Y, Kim YH, Son JW, Kim SH, Choi S, et al. Gender Difference of Blood Pressure Control Rate and Clinical Prognosis in Patients With Resistant Hypertension: Rea orld Observation Study. J Korean Med Sci. 2023; 38(16):e124.

52 

Gerdts E, Sudano I, Brouwers S, Borghi C, Bruno RM, Ceconi C, et al. Sex differences in arterial hypertension. Eur Heart J. 2022; 43(46):4777–88.

53 

Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension. 2013; 61(6):1360–83.

54 

Montero D, Walther G, Dia anestro C, Pyke KE, Padilla J. Microvascular Dilator Function in Athletes: A Systematic Review and Meta-analysis. Med Sci Sports Exerc. 2015; 47(7):1485–94.

55 

Puddey IB, Beilin LJ. Alcohol is bad for blood pressure. Clin Exp Pharmacol Physiol. 2006; 33(9):847–52.

Copyright: Institute of Sport. This is an Open Access article distributed under the terms of the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/). This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.